ALLURION TECHNOLOGIES, INC. 8-K

What Happened

• Allurion Technologies, Inc. (filed March 2, 2026) announced it received a Delisting Notice from NYSE staff saying it does not meet Section 802.01B continued listing standards and that the Exchange will commence delisting proceedings. The Company intends to appeal the NYSE staff determination and request review by the NYSE’s Committee. The Company’s common stock and warrants will continue to trade on the NYSE during the review period, subject to other listing requirements.

Key Details

• NYSE standard at issue (Section 802.01B): maintain either at least $50 million in stockholders’ equity or at least $50 million in total market capitalization on a 30‑trading‑day average basis.
• Dates: Delisting Notice announced March 2, 2026; Company previously received a related NYSE notice on August 29, 2024.
• Securities: common stock (par value $0.0001) and warrants (each warrant to purchase 0.056818 shares, $202.50 exercise price) will remain listed while the appeal is pending.
• Remedial steps noted: ongoing negotiations with creditors and security holders, capital‑raising efforts, and a previously announced agreement to exchange outstanding debt for preferred stock (subject to conditions) and completion of a warrant inducement transaction on February 24, 2026.

Why It Matters

• If delisted, the Company warned this could materially reduce liquidity and market price for its common stock and warrants, make it harder to attract investors or raise equity financing, limit use of registration statements to sell freely tradable securities, and impair its ability to grant equity incentives. The filing also reiterates forward‑looking statement risks and that there is no assurance an appeal or other actions will achieve compliance.